STOCK TITAN
  1. Home
  2. Sec-filings
  3. MET
  4. [8-K] METLIFE INC Reports Material Event

MetLife (NYSE: MET) issues preliminary Q2 2026 variable investment income range

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

MetLife, Inc. released preliminary figures for its variable investment income for the quarter ended June 30, 2026. The company currently estimates this income will be between $220 million and $270 million (pre-tax), which it contrasts with its full-year 2026 variable investment income guidance of approximately $1.6 billion (pre-tax).

Variable investment income reflects returns from private equity, real estate and other funds, as well as prepayment fees. MetLife emphasizes that these numbers are unaudited, based on information available to management as of the disclosure date, and may differ materially once full closing procedures are complete. The company cautions readers not to rely on these estimates as a substitute for full U.S. GAAP financial statements or to infer performance for future periods.

Positive

  • None.

Negative

  • None.

Insights

MetLife flags an early look at Q2 2026 variable investment income, framed clearly as preliminary and subject to change.

MetLife estimates Q2 2026 variable investment income of $220–$270 million pre-tax, versus full-year 2026 guidance of about $1.6 billion. This line captures performance from private equity, real estate and other funds, plus prepayment fees, which can be volatile.

The disclosure is furnished under Regulation FD, giving markets an early view before the full earnings release scheduled for August 5, 2026. The company stresses the estimates are unaudited and that actual results after completing closing procedures could differ materially, so the informational value is directional rather than definitive.

For investors, this mainly frames expectations around one component of earnings, with the broader picture to come in the full quarterly release and financial supplement for the period ended June 30, 2026. The filing does not alter guidance but shows how one quarter may track against the full-year variable investment income outlook.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Estimated Q2 2026 variable investment income (low end) $220 million pre-tax Quarter ended June 30, 2026; preliminary estimate
Estimated Q2 2026 variable investment income (high end) $270 million pre-tax Quarter ended June 30, 2026; preliminary estimate
Full-year 2026 variable investment income guidance $1.6 billion pre-tax (approx.) Full-year 2026 guidance for variable investment income
Quarter covered Quarter ended June 30, 2026 Period for preliminary variable investment income estimate
Planned earnings release date August 5, 2026 Scheduled release of quarterly earnings and financial supplement
variable investment income financial
"the Company estimates that its variable investment income will be approximately $220 million to $270 million (pre-tax)"
Variable investment income is the portion of returns from assets—like dividends, interest, or portfolio gains—that can rise or fall over time instead of staying fixed. Investors care because it makes earnings less predictable and can change cash flow or reported profits; think of it like a farmer’s crop yield that varies year to year, affecting how much money is available for expenses, reinvestment, or payouts to shareholders.
prepayment fees financial
"Variable investment income includes private equity, real estate and other funds and prepayment fees."
Regulation FD regulatory
"Item 7.01 Regulation FD Disclosure. MetLife, Inc. (the "Company") is furnishing this"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
U.S. GAAP financial
"These preliminary financial results should not be viewed as a substitute for full financial statements prepared in accordance with U.S. GAAP."
U.S. GAAP is a set of rules and standards that companies in the United States follow to prepare their financial reports. It helps ensure that financial information is consistent and clear, so investors and others can compare and understand a company's financial health easily.
forward-looking statements regulatory
"The forward-looking statements in this disclosure, which use terms such as “estimates,” “guidance,” “preliminary,” and “will,” are based on assumptions and expectations"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

What variable investment income did MetLife (MET) preliminarily estimate for Q2 2026?
MetLife currently estimates Q2 2026 variable investment income at $220 million to $270 million pre-tax. This estimate is unaudited, based on information available to management, and may change once full financial closing procedures for the quarter are completed.

How does MetLife’s Q2 2026 variable investment income estimate compare with its 2026 guidance?
MetLife compares its Q2 2026 variable investment income estimate of $220–$270 million pre-tax to full-year 2026 guidance of about $1.6 billion pre-tax. This context highlights how one quarter’s performance relates to the annual outlook for this income category.

What does MetLife include in variable investment income for Q2 2026?
MetLife states that variable investment income for Q2 2026 includes private equity, real estate and other funds, along with prepayment fees. These components can be more volatile than traditional fixed-income investments, which is why the company provides a specific preliminary update.

When will MetLife release full Q2 2026 earnings and financial details?
MetLife plans to release its quarterly earnings and quarterly financial supplement for the quarter ended June 30, 2026, on August 5, 2026. The preliminary variable investment income figures are intended as early information ahead of that full release.

Are MetLife’s Q2 2026 variable investment income figures audited or final?
No. MetLife clearly notes the Q2 2026 variable investment income figures are estimated and unaudited. The company has not completed its financial closing procedures, so actual results for the quarter could differ materially from these preliminary estimates.

Does MetLife treat this preliminary variable investment income disclosure as filed financial statements?
MetLife furnishes this information under Item 7.01 of Regulation FD and specifies it is not deemed “filed” for Section 18 of the Exchange Act. It also is not automatically incorporated into Securities Act filings unless specifically referenced.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
0001099219false00010992192026-06-292026-06-290001099219us-gaap:CommonStockMember2026-06-292026-06-290001099219us-gaap:SeriesAPreferredStockMember2026-06-292026-06-290001099219us-gaap:SeriesEPreferredStockMember2026-06-292026-06-290001099219us-gaap:SeriesFPreferredStockMember2026-06-292026-06-29

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549  
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 29, 2026
METLIFE, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
 
1-1578713-4075851
(Commission File Number)(IRS Employer Identification No.)
200 Park Avenue,New York,NY10166-0188
(Address of Principal Executive Offices)(Zip Code)
(212) 578-9500
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report) 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01METNew York Stock Exchange
Floating Rate Non-Cumulative Preferred Stock,
Series A, par value $0.01		MET PRANew York Stock Exchange
Depositary Shares, each representing a 1/1,000th
interest in a share of 5.625% Non-Cumulative
Preferred Stock, Series E		MET PRENew York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series FMET PRF
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company    ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐


Item 7.01 Regulation FD Disclosure.
MetLife, Inc. (the "Company") is furnishing this Current Report on Form 8-K to disclose preliminary information regarding variable investment income prior to the availability of the Company’s quarterly earnings release and quarterly financial supplement for the quarter ended June 30, 2026, scheduled for release on August 5, 2026.
Based on preliminary results received to date, for the quarter ended June 30, 2026, the Company estimates that its variable investment income will be approximately $220 million to $270 million (pre-tax), which compares to full-year 2026 guidance of approximately $1.6 billion (pre-tax). Variable investment income includes private equity, real estate and other funds and prepayment fees.
The preliminary financial information presented above for the quarter ended June 30, 2026, is estimated and unaudited and has been prepared in good faith on a basis consistent with prior periods based on information available to management as of the date hereof; however, we have not completed our financial closing procedures for the quarter ended June 30, 2026, and our actual results could be materially different from these preliminary financial results. As a result, prospective investors should exercise caution in relying on this information and should not draw any inferences from this information regarding financial or operating data not provided. These preliminary financial results should not be viewed as a substitute for full financial statements prepared in accordance with U.S. GAAP. In addition, these preliminary financial results are not necessarily indicative of the results to be achieved in any future period.
The forward-looking statements in this disclosure, which use terms such as “estimates,” “guidance,” “preliminary,” and “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife, Inc.’s results could differ materially from those it expresses or implies in forward-looking statements. MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved.
As provided in General Instruction B.2 of Form 8-K, the information provided pursuant to this Item 7.01 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

2

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
METLIFE, INC.
By:/s/ Adrienne O’Neill
Name:Adrienne O’Neill
Title:Executive Vice President and
Chief Accounting Officer
Date: June 29, 2026
3

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Other Documents